Simulations Plus (SLP) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results
November 11, 2016 4:01 PM EST
Full Fiscal Year Pharmaceutical Software and Services Up 9.1%;
Earnings
per share $0.29, up 27.5% over prior year
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August 31, 2016.
Results for the 2016 fiscal year (FY16):
Revenues were $19.97 million, representing an increase of 9.1% over $18.31 million in FY15 Gross profit was up 10.4% to $15.4 million, an increase of $1.45 million from... More